4.7 Article

Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity

Related references

Note: Only part of the references are listed.
Review Oncology

Context-dependent transcriptional regulations of YAP/TAZ in cancer

Yibo Guo et al.

Summary: This article provides an overview of the core components and upstream regulators of Hippo-YAP/TAZ signaling in mammals, and systematically summarizes the identified transcription factors or partners responsible for the downstream transcriptional output of YAP/TAZ in various cancers.

CANCER LETTERS (2022)

Review Biochemistry & Molecular Biology

The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises

Angel Ortega et al.

Summary: Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are essential for cell growth regulation, embryonic development, regeneration, proliferation, and cancer. Their activation leads to the release of the transcriptional enhanced associate domain (TEAD) from its repressors, resulting in various biological effects. Overexpression of YAP/TAZ is associated with cancer stem cells and tumor resistance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

PI3K/Akt/YAP signaling promotes migration and invasion of DLD-1 colorectal cancer cells

Tomoya Takeda et al.

Summary: This study found that YAP protein is associated with migration and invasion of CRC cells. Silencing YAP expression or using a drug to inhibit YAP can suppress the migration and invasion of CRC cells.

ONCOLOGY LETTERS (2022)

Review Biochemistry & Molecular Biology

Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling

Akshita B. Bhatt et al.

Summary: Extracellular signal-regulated kinase 5 (ERK5) is a crucial regulator of cancer progression, tumor relapse, and poor patient survival. Activation of the ERK5 pathway induces epithelial to mesenchymal transition (EMT) and metastases by regulating various downstream targets, such as myocyte-specific enhancer factor 2c (MEF2C) and activator protein-1 (AP-1). Targeting the ERK5 signaling pathway using small molecule inhibitors and knockdown approaches can inhibit or reverse EMT and metastases in cancer.

BIOMOLECULES (2021)

Article Oncology

Yap1-2 Isoform Is the Primary Mediator in TGF-β1 Induced EMT in Pancreatic Cancer

Chao Gao et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive and resistant to traditional therapies. The alternative splicing of YAP1 mRNA results in 8 protein isoforms, with YAP1-2 being more crucial in mediating TGF-beta-induced EMT in PDAC cells and depending on AKT signaling.

FRONTIERS IN ONCOLOGY (2021)

Review Cell Biology

Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View

Yong Suk Cho et al.

Summary: The Hippo signaling pathway is an evolutionarily conserved tumor suppressor pathway that controls tissue growth and organ size by regulating cell proliferation and death, and is implicated in a wide range of human cancers. It consists of a kinase cascade regulated by various upstream signals.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Dynamic EMT: a multi-tool for tumor progression

Simone Brabletz et al.

Summary: The process of epithelial-mesenchymal transition (EMT) is critical for embryonic development and plays a key role in cancer progression by inducing changes in cell characteristics and motility. Targeting EMT therapeutically could be a promising approach to interfere with tumor progression on multiple levels.

EMBO JOURNAL (2021)

Review Oncology

Emerging Principles in the Transcriptional Control by YAP and TAZ

Alejandro Lopez-Hernandez et al.

Summary: YAP and TAZ are crucial transcriptional cofactors that integrate signals to generate context-specific responses, with implications in both physiological and pathological settings. They play essential roles in embryonic development, regeneration, and cancer progression. Understanding their molecular mechanisms of transcriptional control and the pathways they regulate could offer therapeutic opportunities for YAP/TAZ-driven tumors.

CANCERS (2021)

Review Cell Biology

Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression

Xiaomin Cai et al.

Summary: Biophysical cues, such as mechanical properties, play a critical role in tissue growth and homeostasis. YAP and TAZ are key mechanotransducers that control transcriptional programs for cell proliferation, differentiation, and transformation. However, the regulatory mechanisms and downstream transcriptome responses of YAP/TAZ signaling remain largely unknown.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Yes-Associated Protein Is Required for ZO-1-Mediated Tight-Junction Integrity and Cell Migration in E-Cadherin-Restored AGS Gastric Cancer Cells

Seon-Young Kim et al.

Summary: Yes-associated protein (YAP) regulates cell migration by influencing ZO-1, potentially through the NF-kappa B signaling pathway. The association of YAP with ZO-1 via angiomotin (AMOT) at TJs at high expression levels helps maintain TJ integrity.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

Impact of ERK5 on the Hallmarks of Cancer

Barbara Stecca et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis

John M. Lamar et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4

Francesca Zanconato et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Reciprocal inhibition of YAP/TAZ and NF-κB regulates osteoarthritic cartilage degradation

Yujie Deng et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

YAP promotes myogenic differentiation via the MEK5-ERK5 pathway

Ting-Huan Chen et al.

FASEB JOURNAL (2017)

Review Oncology

YAP/TAZ at the Roots of Cancer

Francesca Zanconato et al.

CANCER CELL (2016)

Article Cell Biology

Erk5 Is a KeyRegulator of Naive-Primed Transition and Embryonic Stem Cell Identity

Charles A. C. Williams et al.

CELL REPORTS (2016)

Article Cell Biology

YAP Induces Human Naive Pluripotency

Han Qin et al.

CELL REPORTS (2016)

Article Multidisciplinary Sciences

TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure

Marco De Santis Puzzonia et al.

PLOS ONE (2016)

Article Biochemistry & Molecular Biology

NDR Functions as a Physiological YAP1 Kinase in the Intestinal Epithelium

Lei Zhang et al.

CURRENT BIOLOGY (2015)

Review Developmental Biology

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

Xaralabos Varelas

DEVELOPMENT (2014)

Review Biochemistry & Molecular Biology

YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth

Boon Chuan Low et al.

FEBS LETTERS (2014)

Article Biochemistry & Molecular Biology

Evidence for a common progenitor of epithelial and mesenchymal components of the liver

A. Conigliaro et al.

CELL DEATH AND DIFFERENTIATION (2013)

Review Cell Biology

ERK5: Structure, regulation and function

Gopika N. Nithianandarajah-Jones et al.

CELLULAR SIGNALLING (2012)

Article Multidisciplinary Sciences

Role of YAP/TAZ in mechanotransduction

Sirio Dupont et al.

NATURE (2011)

Article Biochemistry & Molecular Biology

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway

Revati J. Tatake et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Biochemistry & Molecular Biology

Isolation and characterization of a murine resident liver stem cell

A. Conigliaro et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Biochemistry & Molecular Biology

Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation

Hiroko Morimoto et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Genetics & Heredity

Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice

M Hayashi et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2004)

Article Multidisciplinary Sciences

Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects

CP Regan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Multidisciplinary Sciences

A system for stable expression of short interfering RNAs in mammalian cells

TR Brummelkamp et al.

SCIENCE (2002)